Market Cap

Medistim ASA Market Capitalization:

kr3.13 Billion

NOK as of July 1, 2024

US$293.7 Million

business Medistim ASA Company Profile

Medistim ASA Main Stock Listing

OSE: MEDI

Market Capitalization History of Medistim ASA

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Medical Devices
Company Market Cap (USD)
Abbott $178.02 B
Stryker Corporation $126.48 B
Boston Scientific Corporation $112.32 B
Medtronic $98.95 B
Edwards Lifesciences Corporation $55.63 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Medistim ASA market cap

Date Market Cap YoY Change
Jan. 1, 2024 kr3.91 B -6.75%
Jan. 1, 2023 kr4.20 B -24.59%
Jan. 1, 2022 kr5.56 B 19.61%
Jan. 1, 2021 kr4.65 B 16.97%
Jan. 1, 2020 kr3.98 B 215.03%
Jan. 1, 2019 kr1.26 B -8.95%
Jan. 1, 2018 kr1.39 B 5.56%
Jan. 1, 2017 kr1.31 B 33.95%
Jan. 1, 2016 kr980.4 M 85.34%
Jan. 1, 2015 kr529.0 M 23.40%
Jan. 1, 2014 kr428.7 M 2.62%
Jan. 1, 2013 kr417.7 M 9.57%
Jan. 1, 2012 kr381.2 M -10.68%
Jan. 1, 2011 kr426.8 M -6.40%
Jan. 1, 2010 kr456.0 M 61.29%
Jan. 1, 2009 kr282.7 M -13.89%
Jan. 1, 2008 kr328.3 M 4.65%
Jan. 1, 2007 kr313.7 M 25.55%
Jan. 1, 2006 kr249.9 M 33.01%
Jan. 1, 2005 kr187.9 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Medistim ASA Categories

languages Healthcare languages Medical Devices

Stocks & Indices

Medistim ASA has the following listings and related stock indices.


Stock: OSE: MEDI

Stock: FSX: MD1

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.